Clinical Trials Browser

Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms

Breast Neoplasms

Breast Neoplasms

Neurofibroma, Neurofibromatosis 1

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Adenomatous Polyposis Coli, Colorectal Neoplasms

Colorectal Neoplasms

Lymphangioleiomyomatosis

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Adenomatous Polyposis Coli, Colorectal Neoplasms

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast

Prostatic Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Pancreatic Neoplasms

Breast Neoplasms

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Leukemia, Lymphoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms

Prostatic Hyperplasia, Lower Urinary Tract Symptoms

Head and Neck Neoplasms, Stomatitis, Mucositis

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms

Laryngeal papillomatosis, Papilloma

Brain Neoplasms, Glioblastoma

Clinical Trials

Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma

Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Medical Treatment of "High-Risk" Neurofibromas

Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers

Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver

COLA

Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme

Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis

Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors

S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women

Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer

ADAPT

UAB0040

Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer

Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma

Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)

Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer

Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT

Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels

Cox-2 Inhibition in Radiation-induced Oral Mucositis

Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery

Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer

Celebrex (Celecoxib) Treatment of Laryngeal Papilloma

6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients